Novo Nordisk

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments.

CEO

Maziar Mike Doustdar

CEOMaziar Mike Doustdar

Employees

68,794

Employees68,794

Headquarters

Bagsværd, Capital Region

HeadquartersBagsværd, Capital Region

Founded

1923

Founded1923

Employees

68,794

Employees68,794

NVO Key Statistics

Market cap

167.77B

Market cap167.77B

Price-Earnings ratio

9.13

Price-Earnings ratio9.13

Dividend yield

3.29%

Dividend yield3.29%

Average volume

18.77M

Average volume18.77M

High today

$37.69

High today$37.69

Low today

$37.13

Low today$37.13

Open price

$37.64

Open price$37.64

Volume

10.26M

Volume10.26M

52 Week high

$64.16

52 Week high$64.16

52 Week low

$35.12

52 Week low$35.12

NVO News

Reuters 15h

US FDA extends review of Novo Nordisk's hemophilia drug over facility issues - Reuters

...

The Motley Fool 17h

Novo Nordisk Strikes Nearly $4 Billion in 2 Deals. Here's What That Means for Investors

Novo Nordisk (NVO -0.21%) is looking to maintain its position in the weight-loss market and one-up its most important competitor, Eli Lilly (LLY -0.61%). To tha...

TipRanks 21h

Novo Nordisk Tests Zenagamtide Dosing to Sharpen Its Obesity Drug Pipeline

Novo Nordisk (NVO) announced an update on their ongoing clinical study. The study Investigating the Effect of Post-dose Meal Timings and Water Volume at Dosing...

More NVO News

The Motley Fool 21h

Novo Nordisk vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?

As the global healthcare landscape shifts toward weight-loss treatments and chronic care, investors are weighing two giants. Should you invest in Novo Nordisk A...

Simply Wall St 1d

Novo Nordisk Stock Looks Reasonable Given Uncertain Long Term Earnings

has seen a steep share price reset in recent years, and the question now is whether the current valuation still lines up with the earnings power investors are p...

Benzinga 2d

Over 88% Of Wegovy Trial Participants Achieve Normal Liver Fat Levels, Novo Reports

Novo Nordisk A/S (NYSE:NVO) on Thursday presented a post hoc analysis from a STEP UP trial sub-population, indicating that Wegovy (pooled semaglutide 7.2 and 2....

Benzinga 3d

Novo Nordisk Says Next-Gen Obesity Drug Reduces Food Noise, Drives Weight Loss

Novo Nordisk A/S (NYSE:NVO) on Wednesday revealed new clinical and real-world data at the 2026 European Association for the Study of Diabetes (EASD) Annual Meet...

TipRanks 3d

Novo Nordisk Opens a New Front in Cardiometabolic Care With Early-Stage Anti-Inflammatory Study

Novo Nordisk (NVO) announced an update on their ongoing clinical study. Novo Nordisk Explores New Anti-Inflammatory Pathway for Heart and Metabolic Health. Thi...

TipRanks 3d

Novo Nordisk Tests Cagrisema Switch Strategy to Strengthen Its Diabetes Franchise

Novo Nordisk (NVO) announced an update on their ongoing clinical study. Novo Nordisk Studies Key Switch From Ozempic to Cagrisema for Type 2 Diabetes The stud...

Nasdaq 3d

Novo Nordisk Gives Uninspiring Outlook

Investors were hopeful for a better growth estimate. Missed AI’s "Act 1"? Act 2 Could Be 15x Bigger. Most investors think they missed the AI boat because they...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.